MutaPlax cII-Select Kit
Company
Epicentre Technologies Corporation
Use
Measures mutation frequencies of lambda-based in vivo mutagenesis systems using a new positive selection method.
Features
Includes MutaPlax™ lambda packaging extracts from NM759 and an extract from strain BHB2688.
NIH Contribution
A novel assay for the detection of mutations in the lambda transgene
HHS Institute/Agency
NCI
Inventor(s)
S. Garges, S. Adhya, J. Jakubczak, G. Merlino
Year
1996
Tech Cat
Research Reagent
